Evidence against hypothalamic-pituitary-adrenal axis suppression in the antidiabetic action of leptin

Journal of Clinical Investigation

Volumn 125, Issue 12, 2015, Pages 4587-4591

  Morton, Gregory J ^a   Meek, Thomas H ^a   Matsen, Miles E ^a   Schwartz, Michael W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTERONE; CORTICOTROPIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; GLUCOSE; INSULIN; LEPTIN; GLUCOSE BLOOD LEVEL;

ADRENAL GLAND; ADRENALECTOMY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIDIABETIC ACTIVITY; ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; CORTICOSTEROID BLOOD LEVEL; CORTICOSTERONE BLOOD LEVEL; CORTICOTROPIN BLOOD LEVEL; DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HYPERGLYCEMIA; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; INSULIN BLOOD LEVEL; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; ANIMAL; BLOOD; DIABETES MELLITUS, EXPERIMENTAL; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; METABOLISM; PATHOLOGY;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LEPTIN; PITUITARY-ADRENAL SYSTEM; RATS;

EID: 84948843974     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI82723     Document Type: Article

References (21)

1. Chinookoswong N, Wang JL, Shi ZQ. Leptin restores euglycemia and normalizes glucose turnover in insulin-deficient diabetes in the rat. Diabetes. 1999;48(7):1487-1492.
2. Yu X, Park BH, Wang MY, Wang ZV, Unger RH. Making insulin-deficient type 1 diabetic rodents thrive without insulin. Proc Natl Acad Sci USA. 2008;105(37):14070-14075.
3. Fujikawa T, Chuang JC, Sakata I, Ramadori G, Coppari R. Leptin therapy improves insulin-deficient type 1 diabetes by CNS-dependent mechanisms in mice. Proc Natl Acad Sci USA. 2010;107(40):17391-17396.
4. German JP, et al. Leptin activates a novel CNS mechanism for insulin-independent normalization of severe diabetic hyperglycemia. Endocrinology. 2011;152(2):394-404.
5. Hidaka S, et al. Chronic central leptin infusion restores hyperglycemia independent of food intake and insulin level in streptozotocin-induced diabetic rats. FASEB J. 2002;16(6):509-518.
6. Lin CY, Higginbotham DA, Judd RL, White BD. Central leptin increases insulin sensitivity in streptozotocin-induced diabetic rats. Am J Physiol Endocrinol Me tab. 2002;282(5):E1084-E1091.
7. Meek TH, et al. Leptin action in the ventrome-dial hypothalamic nucleus is sufficient, but not necessary, to normalize diabetic hyperglycemia. Endocrinology. 2013;154(9):3067-3076.
8. Havel PJ, et al. Marked and rapid decreases of circulating leptin in streptozotocin diabetic rats: reversal by insulin. Am J Physiol. 1998; 274(5 pt 2):R1482-R1491.
9. German JP, et al. Leptin deficiency causes insulin resistance induced by uncontrolled diabetes. Diabetes. 2010;59(7):1626-1634.
10. Sindelar DK, Havel PJ, Seeley RJ, Wilkinson CW, Woods SC, Schwartz MW. Low plasma leptin levels contribute to diabetic hyperphagia in rats. Diabetes. 1999;48(6):1275-1280.
11. Matsen ME, et al. In uncontrolled diabetes, thyroid hormone and sympathetic activators induce thermogenesis without increasing glucose uptake in brown adipose tissue. Am J Physiol Endocrinol Metab. 2013;304(7):E734-E746.
12. Schwartz MW, Strack AM, Dallman MF. Evidence that elevated plasma corticosterone levels are the cause of reduced hypothalamic corticotrophin-releasing hormone gene expression in diabetes. Regul Pept. 1997;72(2-3):105-112.
13. Strack AM, Sebastian RJ, Schwartz MW, Dallman MF. Glucocorticoids and insulin: reciprocal signals for energy balance. Am J Physiol. 1995; 268(1 pt 2):R142-R149.
14. Opherk C, et al. Inactivation of the glucocor-ticoid receptor in hepatocytes leads to fasting hypoglycemia and ameliorates hyperglycemia in streptozotocin-induced diabetes mellitus. Mol Endocrinol. 2004;18(6):1346-1353.
15. Perry RJ, et al. Leptin reverses diabetes by suppression of the hypothalamic-pituitary-adrenal axis. Nat Med. 2014;20(7):759-763.
16. Zuo ZF, et al. RU486 (mifepristone) ameliorates cognitive dysfunction and reverses the down-regulation of astrocytic N-myc downstream-regulated gene 2 in streptozotocin-induced type-1 diabetic rats. Neuroscience. 2011;190:156-165.
17. Schwartz MW, et al. Cooperation between brain and islet in glucose homeostasis and diabetes. Nature. 2013;503(7474):59-66.
18. Kovács KJ, Földes A, Sawchenko PE. Gluco-corticoid negative feedback selectively targets vasopressin transcription in parvo-cellular neurosecretory neurons. J Neurosci. 2000;20(10):3843-3852.
19. Meek TH, et al. Evidence that in uncontrolled diabetes, hyperglucagonemia is required for ketosis but not for increased hepatic glucose production or hyperglycemia. Diabetes. 2015;64(7):2376-2387.
20. Cryer PE. Glucose counterregulatory hormones: physiology, pathophysiology, and relevance to clinical hypoglycemia. In: LeRoith D, Taylor SI, Olefsky JM, eds. Diabetes Mellitus: A Fundamental And Clinical Text. 3rd ed. Philadelphia, Pennsylvania, USA: Lippincott Williams & Wilkins; 2004:199-206.
21. Perry RJ, Lee S, Ma L, Zhang D, Schlessinger J, Shulman GI. FGF1 and FGF19 reverse diabetes by suppression of the hypothalamic-pituitary-adrenal axis. Nat Commun. 2015;6:6980.